Five things to know:
1. Net sales globally were $625.7 million, a 63.1% increase year over year, according to a news release.
2. U.S. net sales grew 60.3% year over year. Sales growth was driven by the NuVasive merger and increased spine and enabling technology sales.
3. Musculoskeletal net sales were $587.4 million, and enabling technology sales were $38.3 million.
4. Net income was $51.8 million, largely driven by sales and a decrease in acquisition-related costs.
5. Globus Medical raised its full-year guidance and expects revenue to reach $2.49 billion to $2.5 billion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
